Endoskopische Therapie bei Adipositas und Diabetes mellitus

 

 Buy Article Permissions and Reprints

Abstract

Obesity and diabetes are associated with increased mortality and morbidity. After failure of conservative therapy such as pharmacotherapy and lifestyle management, bariatric treatment is indicated for selected patients. Endoscopic techniques for weight reduction are well-established treatment for obese population who do not qualify for or are not willing to undergo bariatric surgery. This article is an overview of currently applied endoscopic techniques and summarized current published data.

Publication History

Article published online:
23 January 2023

© 2023. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

• Literatur

• 1 Kelly T, Yang W, Chen CS. et al. Global burden of obesity in 2005 and projections to 2030. Int J Obes (Lond) 2008; 32: 1431-1437 DOI: 10.1038/ijo.2008.102.
  CrossrefPubMedGoogle Scholar
• 2 Guh DP, Zhang W, Bansback N. et al. The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health 2009; 9: 88 DOI: 10.1186/1471-2458-9-88.
  CrossrefPubMedGoogle Scholar
• 3 Fontaine KR, Redden DT, Wang C. et al. Years of life lost due to obesity. JAMA 2003; 289: 187-193 DOI: 10.1001/jama.289.2.187.
  CrossrefPubMedGoogle Scholar
• 4 Heidemann C, Scheidt-Nave C. Prävalenz, Inzidenz und Mortalität von Diabetes mellitus bei Erwachsenen in Deutschland – Bestandsaufnahme zur Diabetes-Surveillance. J Health Monit 2017; 3 DOI: 10.17886/rki-gbe-2017-050.
  CrossrefPubMedGoogle Scholar
• 5 Sarwar N, Gao P, Seshasai SR. et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet 2010; 375: 2215-2222 DOI: 10.1016/s0140-6736(10)60484-9.
  CrossrefPubMedGoogle Scholar
• 6 Reitzle L, Schmidt C, Du Y. et al. Einschätzungen zur Prävalenz mikrovaskulärer Folgeerkrankungen bei Diabetes mellitus in Deutschland. Analyse von Versichertendaten aller gesetzlichen Krankenkassen für die Jahre 2012 und 2013. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2020; 63: 1219-1230 DOI: 10.1007/s00103-020-03211-x.
  CrossrefPubMedGoogle Scholar
• 7 Sullivan S, Edmundowicz SA, Thompson CC. Endoscopic Bariatric and Metabolic Therapies: New and Emerging Technologies. Gastroenterology 2017; 152: 1791-1801 DOI: 10.1053/j.gastro.2017.01.044.
  CrossrefPubMedGoogle Scholar
• 8 AWMF. S3-Leitlinie Chirurgie der Adipositas und metabolischer Erkrankungen. AWMF-Register-Nr. 088-001; 2018. Im Internet:. https://www.awmf.org/uploads/tx_szleitlinien/088-001l_S3_Chirurgie-Adipositas-metabolische-Erkrankugen_2018-02.pdf ; Stand: 13.10.2022
  PubMedGoogle Scholar
• 9 Abu Dayyeh BK, Kumar N, Edmundowicz SA. et al. ASGE Bariatric Endoscopy Task Force systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting endoscopic bariatric therapies. Gastrointest Endosc 2015; 82: 425-438.e425 DOI: 10.1016/j.gie.2015.03.1964.
  CrossrefPubMedGoogle Scholar
• 10 Gómez V, Woodman G, Abu Dayyeh BK. Delayed gastric emptying as a proposed mechanism of action during intragastric balloon therapy: Results of a prospective study. Obesity (Silver Spring) 2016; 24: 1849-1853 DOI: 10.1002/oby.21555.
  CrossrefPubMedGoogle Scholar
• 11 Turkeltaub JA, Edmundowicz SA. Endoscopic Bariatric Therapies: Intragastric Balloons, Tissue Apposition, and Aspiration Therapy. Curr Treat Options Gastroenterol 2019; 17: 187-201 DOI: 10.1007/s11938-019-00232-7.
  CrossrefPubMedGoogle Scholar
• 12 Jamal MH, Al-Kanawati N, ElAbd R. et al. A Study Examining the Orbera365 Intragastric Balloon Safety and Effects on Weight Loss. Obes Surg 2021; 31: 5342-5347 DOI: 10.1007/s11695-021-05729-8.
  CrossrefPubMedGoogle Scholar
• 13 Popov VB, Ou A, Schulman AR. et al. The Impact of Intragastric Balloons on Obesity-Related Co-Morbidities: A Systematic Review and Meta-Analysis. Am J Gastroenterol 2017; 112: 429-439 DOI: 10.1038/ajg.2016.530.
  CrossrefPubMedGoogle Scholar
• 14 Tate CM, Geliebter A. Intragastric Balloon Treatment for Obesity: Review of Recent Studies. Adv Ther 2017; 34: 1859-1875 DOI: 10.1007/s12325-017-0562-3.
  CrossrefPubMedGoogle Scholar
• 15 Loo JH, Lim YH, Seah HL. et al. Intragastric Balloon as Bridging Therapy Prior to Bariatric Surgery for Patients with Severe Obesity (BMI ≥ 50 kg/m(2)): a Systematic Review and Meta-analysis. Obes Surg 2022; 32: 489-502 DOI: 10.1007/s11695-021-05772-5.
  CrossrefPubMedGoogle Scholar
• 16 Yorke E, Switzer NJ, Reso A. et al. Intragastric Balloon for Management of Severe Obesity: a Systematic Review. Obes Surg 2016; 26: 2248-2254 DOI: 10.1007/s11695-016-2307-9.
  CrossrefPubMedGoogle Scholar
• 17 Tate CM, Geliebter A. Intragastric Balloon Treatment for Obesity: FDA Safety Updates. Adv Ther 2018; 35: 1-4 DOI: 10.1007/s12325-017-0647-z.
  CrossrefPubMedGoogle Scholar
• 18 Chan DL, Cruz JR, Mui WL. et al. Outcomes with Intra-gastric Balloon Therapy in BMI < 35 Non-morbid Obesity: 10-Year Follow-Up Study of an RCT. Obes Surg 2021; 31: 781-786 DOI: 10.1007/s11695-020-04986-3.
  CrossrefPubMedGoogle Scholar
• 19 de Moura EG, Lopes GS, Martins BC. et al. Effects of Duodenal-Jejunal Bypass Liner (EndoBarrier) on Gastric Emptying in Obese and Type 2 Diabetic Patients. Obes Surg 2015; 25: 1618-1625 DOI: 10.1007/s11695-015-1594-x.
  CrossrefPubMedGoogle Scholar
• 20 Sandler BJ, Biertho L, Anvari M. et al. Totally endoscopic implant to effect a gastric bypass: 12-month safety and efficacy outcomes. Surg Endosc 2018; 32: 4436-4442 DOI: 10.1007/s00464-018-6186-0.
  CrossrefPubMedGoogle Scholar
• 21 Abu Dayyeh BK, Acosta A, Camilleri M. et al. Endoscopic Sleeve Gastroplasty Alters Gastric Physiology and Induces Loss of Body Weight in Obese Individuals. Clin Gastroenterol Hepatol 2017; 15: 37-43.e31 DOI: 10.1016/j.cgh.2015.12.030.
  CrossrefPubMedGoogle Scholar
• 22 Li P, Ma B, Gong S. et al. Efficacy and safety of endoscopic sleeve gastroplasty for obesity patients: a meta-analysis. Surg Endosc 2020; 34: 1253-1260 DOI: 10.1007/s00464-019-06889-6.
  CrossrefPubMedGoogle Scholar
• 23 Hedjoudje A, Abu Dayyeh BK, Cheskin LJ. et al. Efficacy and Safety of Endoscopic Sleeve Gastroplasty: A Systematic Review and Meta-Analysis. Clin Gastroenterol Hepatol 2020; 18: 1043-1053.e1044 DOI: 10.1016/j.cgh.2019.08.022.
  Google Scholar
• 24 Sharaiha RZ, Kumta NA, Saumoy M. et al. Endoscopic Sleeve Gastroplasty Significantly Reduces Body Mass Index and Metabolic Complications in Obese Patients. Clin Gastroenterol Hepatol 2017; 15: 504-510 DOI: 10.1016/j.cgh.2016.12.012.
  CrossrefPubMedGoogle Scholar
• 25 Fayad L, Adam A, Schweitzer M. et al. Endoscopic sleeve gastroplasty versus laparoscopic sleeve gastrectomy: a case-matched study. Gastrointest Endosc 2019; 89: 782-788 DOI: 10.1016/j.gie.2018.08.030.
  CrossrefPubMedGoogle Scholar
• 26 López-Nava G, Bautista-Castaño I, Jimenez A. et al. The Primary Obesity Surgery Endolumenal (POSE) procedure: one-year patient weight loss and safety outcomes. Surg Obes Relat Dis 2015; 11: 861-865 DOI: 10.1016/j.soard.2014.09.026.
  CrossrefPubMedGoogle Scholar
• 27 Sullivan S, Swain JM, Woodman G. et al. Randomized sham-controlled trial evaluating efficacy and safety of endoscopic gastric plication for primary obesity: The ESSENTIAL trial. Obesity (Silver Spring) 2017; 25: 294-301 DOI: 10.1002/oby.21702.
  CrossrefPubMedGoogle Scholar
• 28 Hollenbach M, Selig L, Lellwitz S. et al. Endoscopic full-thickness transoral outlet reduction with semicircumferential endoscopic submucosal dissection. Endoscopy 2019; 51: 684-688 DOI: 10.1055/a-0866-9427.
  Article in Thieme ConnectPubMedGoogle Scholar
• 29 Sullivan S, Stein R, Jonnalagadda S. et al. Aspiration therapy leads to weight loss in obese subjects: a pilot study. Gastroenterology 2013; 145: 1245-1252.e1–5 DOI: 10.1053/j.gastro.2013.08.056.
  CrossrefPubMedGoogle Scholar
• 30 Nyström M, Machytka E, Norén E. et al. Aspiration Therapy As a Tool to Treat Obesity: 1- to 4-Year Results in a 201-Patient Multi-Center Post-Market European Registry Study. Obes Surg 2018; 28: 1860-1868 DOI: 10.1007/s11695-017-3096-5.
  CrossrefPubMedGoogle Scholar
• 31 Thompson CC, Abu Dayyeh BK, Kushner R. et al. Percutaneous Gastrostomy Device for the Treatment of Class II and Class III Obesity: Results of a Randomized Controlled Trial. Am J Gastroenterol 2017; 112: 447-457 DOI: 10.1038/ajg.2016.500.
  CrossrefPubMedGoogle Scholar
• 32 van Baar ACG, Haidry R, Rodriguez Grunert L. et al. Duodenal mucosal resurfacing: Multicenter experience implementing a minimally invasive endoscopic procedure for treatment of type 2 diabetes mellitus. Endosc Int Open 2020; 8: E1683-E1689 DOI: 10.1055/a-1244-2283.
  Article in Thieme ConnectPubMedGoogle Scholar
• 33 de Oliveira GHP, de Moura DTH, Funari MP. et al. Metabolic Effects of Endoscopic Duodenal Mucosal Resurfacing: a Systematic Review and Meta-analysis. Obes Surg 2021; 31: 1304-1312 DOI: 10.1007/s11695-020-05170-3.
  CrossrefPubMedGoogle Scholar
• 34 van Baar ACG, Holleman F, Crenier L. et al. Endoscopic duodenal mucosal resurfacing for the treatment of type 2 diabetes mellitus: one year results from the first international, open-label, prospective, multicentre study. Gut 2020; 69: 295-303 DOI: 10.1136/gutjnl-2019-318349.
  CrossrefPubMedGoogle Scholar
• 35 Mingrone G, van Baar AC, Devière J. et al. Safety and efficacy of hydrothermal duodenal mucosal resurfacing in patients with type 2 diabetes: the randomised, double-blind, sham-controlled, multicentre REVITA-2 feasibility trial. Gut 2022; 71: 254-264 DOI: 10.1136/gutjnl-2020-323608.
  CrossrefPubMedGoogle Scholar